News

Pamlico has developed a group of three human IgG monoclonal antibodies intended for the treatment of Streptococcus pneumoniae infections. Main aim of the deal is to develop a

The drug is the first and only therapy approved by the FDA, which demonstrates symptomatic benefit in patients with NOH. NOH is a rare, chronic and often debilitating

Under the deal, DKSH will be responsible for providing registration, importation, warehousing, physical distribution and collection services for Cheplapharm’s products Vesanoid (Tretinoin) and Rohypnol (Flunitrazepam) in Brunei, Hong

The placebo-controlled trial, which enrolled 42 subjects, evaluated whether NM504 administered for four weeks could improve the glucose tolerance of subjects with prediabetes and untreated type 2 diabetes

The European Patent Office has issued a new patent family for Livatag protecting its specific administration scheme. This first delivery should be followed by many others since the

Novartis reported sales of Fingolimod of $1,934m in 2013, representing a 62% increase from 2012. With the issuance of this patent, Mapi intends to develop a generic version

Patent #2007228341 covers the method and composition of matter for three-dimensional (3D) expansion of placental or adipose (fat) stromal cells, Pluristem’s key technology platform. Patent claims also include

Axxess president Daniel Bagi said: "This initial PO we believe is a sign of things to come, and we are very confident Mitch and his team at NPI

The study met its primary objective of protection from bleeds with fewer infusions. In the study, the site-specific PEGylated factor VIII provided protection from bleeds when used prophylactically